Advising DuPont on the merger  of its Nutrition & Biosciences business with IFF  via a Reverse Morris Trust

on its pending ~$55 billion merger with

and simultaneous spin-offs of

on its approximately $60 billion sale to

The Independent Directors of the Board of

on its $40 billion combination with

on its successful defense against $150 billion hostile offer by

on its restructuring affecting over $42 billion of debt

on its ~$79 billion acquisition of

$717 million
Initial Public Offering

on its ~$90 billion acquisition of

the Special Committee of

on the exchange of Class V shares for equity or a cash election, resulting in a public listing of Dell Technologies

on its activism defense against & on its pending $11 billion sale to

on amendments of its credit facilities with aggregate debt of $11bn

on its ~$48 billion offer to acquire

~$1.7 Billion
Initial Public Offering

The Independent Committee of the Board of Directors of

on its pending ~$59 billion acquisition of

on its activism defense against

& on its $14 billion sale to

on its pre-packaged Chapter 11 restructuring of $1.5 billion of debt

on its $2 billion acquisition of

$2.9 billion

Follow-on Offering